Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Managed care company Cigna Corp. more than doubled its spending on federal government lobbying in the second quarter, as it focused on health care reform, Medicare prescription drug programs and other issues.
The Philadelphia insurer spent $560,000 in this year's April-to-June period, up from $260,000 in the same quarter last year, according to reports filed with the Clerk of the House of Representatives. The total also represented an increase from the $400,000 Cigna spent in the first quarter of this year.
Cigna lobbied on the Patient Protection and Affordable Care Act, the health care reform law Congress passed in March that aims to eventually provide coverage for millions of uninsured people. It lobbied on the taxation of employer-provided health benefits and "implementation issues" for the Medicare Advantage and Medicare Part D prescription drug programs, according to the five-page report.
The insurer also lobbied Congress on the Open Access to Courts Act of 2009.
Besides Congress, Cigna also lobbied the White House, the Congressional Budget Office, the Department of Health and Human Services and the Centers for Medicare and Medicaid Services.
Cigna is the fourth-largest publicly traded health insurer based on enrollment, but its product portfolio is broader than many of its competitors. It operates health care, group disability and life segments in the U.S. It also sells individual insurance in several countries and runs an expatriate business that provides coverage for people living outside their home countries.